https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52579 Tue 17 Oct 2023 15:49:01 AEDT ]]> The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50562 Tue 01 Aug 2023 10:19:27 AEST ]]> PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55040 Thu 04 Apr 2024 13:51:52 AEDT ]]> ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53140 Fri 17 Nov 2023 11:42:18 AEDT ]]> B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51515 Fri 08 Sep 2023 12:04:15 AEST ]]>